Using cancer research strategies to develop an anti-coronavirus vaccine

Managing multiple myeloma during the COVID-19 outbreak

Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells

Immune checkpoint based approaches in AML and MDS

CARTs for the treatment of T-cell malignancies

COVID-19: Should we continue using immunomodulatory drugs to treat our patients?

Management of mutation-negative NSCLC

Management of advanced cervical cancer

Working up metastatic NSCLC

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

BCG dosing for bladder cancer: Standard frequency schedule correct